$1.970
-0.113 (-5.74%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
MCRB-Prognose durch Analyse ähnlicher Charts
Alphio's MCRB stock price prediction model matches the current Seres Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.96 (-0.35%). The 1-week path is $1.98 (+0.44%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Seres Therapeutics Inc-Aktien kaufen?
Seres Therapeutics Inc is a good buy right now due to its current price of $1.97, which is significantly lower than its 52-week high of $29.98, indicating substantial upside potential. The forward P/E ratio stands at 10.82, suggesting that the stock is undervalued relative to its future earnings potential. Additionally, the recent positive earnings report showed a net income of $4.6 million for Q2, a turnaround from a loss of $19.9 million in the same quarter last year, which reflects improving financial performance.
MCRB schloss am Friday bei $1.97, nachdem der Kurs -5.74% fallen
Seres Therapeutics Inc (MCRB) last closed at $1.97, losing -5.74%. These facts feed the 1-day and 1-week MCRB price prediction above.
Analystenkonsens
Seres Therapeutics Inc (MCRB): 7 Kaufen, 2 Halten, 0 Verkaufen. Ausblick: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Seres Therapeutics Inc (MCRB) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf MCRB am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für MCRB
Historically the probability of a positive November return for MCRB is 20.45%. January offers the highest probability of a positive month at 42.62%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Ähnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.